BBGBloomberg·23hBusiness
score+0.70
Sellas Life Sciences Stock Triples After Cancer Vaccine Data
Original
Sellas Life Sciences Stock Triples After Cancer Vaccine Data
“Positive framing highlights significant stock gain and successful clinical trial data for a serious disease treatment.”